Biogen
BIIB
#952
Rank
ยฃ16.83 B
Marketcap
ยฃ115.52
Share price
-0.48%
Change (1 day)
-40.30%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ5.46 Billion

According to Biogen's latest financial reports the company's total debt is ยฃ5.46 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Biogen - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ5.75 B5.36%
2022-12-31ยฃ5.46 B-2.94%
2021-12-31ยฃ5.63 B-1.92%
2020-12-31ยฃ5.74 B18.27%
2019-12-31ยฃ4.85 B3.83%
2018-12-31ยฃ4.67 B6.44%
2017-12-31ยฃ4.39 B-16.82%
2016-12-31ยฃ5.28 B19.94%
2015-12-31ยฃ4.40 B1075.27%
2014-12-31ยฃ0.37 B3.73%
2013-12-31ยฃ0.36 B-48.82%
2012-12-31ยฃ0.70 B3.1%
2011-12-31ยฃ0.68 B-12.19%
2010-12-31ยฃ0.77 B14.69%
2009-12-31ยฃ0.67 B-10.5%
2008-12-31ยฃ0.75 B-3.47%
2007-12-31ยฃ0.78 B1493.75%
2006-12-31ยฃ49.36 M95.95%
2005-12-31ยฃ25.19 M-94.31%
2004-12-31ยฃ0.44 B-10.7%
2003-12-31ยฃ0.49 B-8.19%
2002-12-31ยฃ0.54 B1560.02%
2001-12-31ยฃ32.54 M-55.57%
2000-12-31ยฃ73.24 M4.68%
1999-12-31ยฃ69.97 M44.84%
1998-12-31ยฃ48.3 M-13.32%
1997-12-31ยฃ55.73 M44%
1996-12-31ยฃ38.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ49.63 B 808.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ19.10 B 249.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ58.41 B 968.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ54.75 B 901.62%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ29.38 B 437.54%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.16 B-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ20.92 B 282.82%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.14 B-79.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.19 B-59.79%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.57 B-71.13%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands